Diastolic Dysfunction and Pulmonary Hypertension in Sickle Cell Anemia: Is There a Role for L-Carnitine Treatment?

Publisher： Karger

E-ISSN： 1421-9662|115|1-2|91-96

ISSN： 0001-5792

Source： Acta Haematologica, Vol.115, Iss.1-2, 2006-01, pp. : 91-96

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pulmonary endarterectomy as treatment for chronic thromboembolic pulmonary hypertension in sickle cell disease

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 12, 2015-12 ,pp. : E223-E224

John Wiley & Sons Inc

Access to resources Recommend Favorite

L-Carnitine Treatment in Patients with Mild Diastolic Heart Failure Is Associated with Improvement in Diastolic Function and Symptoms

By  

Cardiology, Vol. 116, Iss. 3, 2010-07 ,pp. : 178-182

Karger

Access to resources Recommend Favorite

Pulmonary Hypertension in Sickle-Cell Disease: Comorbidities and Echocardiographic Findings

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-05 ,pp. : 53-60

Karger

Access to resources Recommend Favorite

Increased QT Dispersion in Sickle Cell Disease: Effect of Pulmonary Hypertension

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-03 ,pp. : 1-6

Karger

Access to resources Recommend Favorite

Exercise haemodynamics may unmask the diagnosis of diastolic dysfunction among patients with pulmonary hypertension

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 151-158

John Wiley & Sons Inc

Access to resources Recommend Favorite